United States v. Philip Morris USA, Inc.

United States v. Philip Morris USA, Inc.
Name	United States v. Philip Morris USA, Inc.
Court	United States District Court for the District of Columbia
Full name	United States v. Philip Morris USA, Inc., et al.
Date decided	2006
Citation	449 F. Supp. 2d 1 (D.D.C. 2006)
Judges	Gladys Kessler
Keywords	racketeering, Racketeer Influenced and Corrupt Organizations Act, RICO, tobacco litigation, injunction

United States v. Philip Morris USA, Inc. was a landmark civil racketeering case brought by the United States Department of Justice against major tobacco companies, culminating in a 2006 decision by Judge Gladys Kessler of the United States District Court for the District of Columbia. The ruling found that defendants violated the Racketeer Influenced and Corrupt Organizations Act by engaging in long-term deceptive practices related to cigarette marketing, health risks, and nicotine. The case produced extensive factual findings, injunctive remedies, and a complex appellate history that influenced subsequent public health law, regulatory approaches, and litigation strategies.

Background

The action originated from investigative efforts by the United States Department of Justice that built on prior litigation such as State of Minnesota v. Philip Morris, Inc. and federal and state enforcement programs including the Master Settlement Agreement among state attorneys general and the major tobacco companies like Philip Morris USA, R.J. Reynolds Tobacco Company, Lorillard Tobacco Company, Brown & Williamson Tobacco Corporation, and British American Tobacco. Prominent figures and institutions in related history include Thomas J. Glynn, researchers at National Cancer Institute, litigators from the Civil Division (DOJ), and public health advocates connected to Centers for Disease Control and Prevention, World Health Organization, and American Cancer Society. The DOJ complaint invoked statutes and precedents such as the Racketeer Influenced and Corrupt Organizations Act, decisions from the Supreme Court of the United States on civil procedure, and earlier rulings in tobacco cases like Kessler v. Philip Morris USA.

Litigation and Claims

The DOJ alleged a multi-decade conspiracy by tobacco defendants to mislead the public and deceive regulators about the addictiveness and health consequences of smoking, the manipulation of nicotine, and the safety of "light" and "low-tar" cigarettes. The complaint intertwined evidence and actors from corporate entities including Philip Morris International, Marlboro, Camel, Newport (cigarette), Benson & Hedges, and research organizations like the Tobacco Institute and individuals who testified in congressional hearings such as those before the United States Congress House Committee on Energy and Commerce, the United States Senate Committee on Finance, and historical hearings involving Joseph A. Califano Jr.. Legal theories cited included civil RICO predicates drawn from mail and wire fraud statutes, falsified scientific communications tied to institutions like Harvard Harvard School of Public Health, published epidemiology linked with British Medical Journal, and internal documents uncovered through discovery that referenced meetings in corporate centers such as New York City, Richmond, Virginia, and London.

Trial and Findings

The bench trial presided over by Judge Gladys Kessler assembled vast documentary and testimonial records from whistleblowers, corporate executives, scientists, and regulators including witnesses connected to Food and Drug Administration, National Institutes of Health, Surgeon General (United States), and historical actors like C. Everett Koop and Luther L. Terry. Findings of fact held that defendants engaged in deceptive acts concerning nicotine manipulation, the health effects of secondhand smoke addressed by Environmental Protection Agency, and marketing targeting demographics chronicled by social researchers at Johns Hopkins Bloomberg School of Public Health and Truth Initiative. The court determined that companies violated RICO by conducting an enterprise involving mail and wire fraud and that their public statements and internal strategies constituted racketeering activity, citing patterns similar to those in civil RICO jurisprudence such as decisions from the United States Court of Appeals for the District of Columbia Circuit.

Remedies and Court Orders

Judge Kessler ordered injunctions requiring corrective advertising and disclosures to remedy the effects of defendants' conduct, mandating statements to be disseminated through media outlets including national newspapers and broadcasters like The New York Times, The Washington Post, CNN, and CBS News. Remedies also included prohibitions on future deceptive practices, requirements for corporate compliance programs modeled on consent decrees used in cases involving Enron and Tobacco Master Settlement Agreement enforcement, and oversight mechanisms analogous to relief in complex public health injunctions such as those in Brown v. Board of Education administrative remedies and structured remedies seen in antitrust and environmental cases involving the Antitrust Division (DOJ) and the Environmental Protection Agency. The relief sought to address consumer protection concerns enforced by agencies like the Federal Trade Commission.

Appeals and Subsequent Proceedings

Defendants appealed aspects of the judgment to the United States Court of Appeals for the District of Columbia Circuit and sought review by the Supreme Court of the United States; the appellate proceedings considered interlocutory matters and the scope of equitable relief under RICO. Post-judgment litigation involved disputes over the wording, placement, and duration of corrective statements, drawing in media organizations including Gannett, legal advocacy groups such as the American Civil Liberties Union, and institutions like the Federal Communications Commission regarding broadcast distribution. Some remedial requirements were stayed or altered through appellate rulings and subsequent compliance negotiations, paralleling appellate treatment in other complex civil enforcement matters like FTC v. Wyndham Worldwide and SEC enforcement actions.

Impact and Legacy

The case reshaped litigation strategy against corporate defendants by demonstrating expansive use of civil RICO in public health contexts and influenced public health policy, regulatory frameworks, and academic inquiry at places like Yale School of Medicine and Columbia University Mailman School of Public Health. It amplified efforts by organizations such as Campaign for Tobacco-Free Kids, American Lung Association, and international initiatives under the World Health Organization Framework Convention on Tobacco Control to restrict deceptive marketing and improve disclosure. The decision contributed to scholarship cited in law reviews from institutions like Harvard Law School, Georgetown University Law Center, and NYU School of Law and affected subsequent settlements, enforcement actions, and corporate governance reforms within firms including Altria Group and British American Tobacco plc. Its legacy endures in regulatory debates involving nicotine regulation, public health litigation, and comparative cases in jurisdictions such as Australia and the European Union.

Category:United States case law